COMPANY
Gedeon Richter Plc.
Gedeon Richter Plc.: marketing authorisation holder, trial sponsor for Ganirelix, Teriparatide, as stated by public registers.
Also written as: GEDEON RICHTER PLC.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Ganirelix | GANIRELIX GEDEON RICHTER 0.25 MG/0.5 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PLGB 04854/0193, Authorised Regulator MHRA |
|---|---|
| Teriparatide | Terrosa (EMEA/H/C/003916), Authorised Regulator EMA |
| Teriparatide | TERROSA 20 MG/80 ML SOLUTION FOR INJECTION, PLGB 04854/0177, Authorised Regulator MHRA |
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Teriparatide | 1 registered trial Trial register ClinicalTrials.gov |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.